103 related articles for article (PubMed ID: 25624301)
1. Time to be cautious about prescribing sulfonylureas?
Dwyer M
Br J Gen Pract; 2015 Feb; 65(631):93-4. PubMed ID: 25624301
[No Abstract] [Full Text] [Related]
2. Secondary failure to sulfonylureas in NIDDM. Are sulfonylureas still useful?
Menon KN; Seshadri MS
J Assoc Physicians India; 1990 Aug; 38(8):533-4. PubMed ID: 2123182
[No Abstract] [Full Text] [Related]
3. Discrepancies among consensus documents, guidelines, clinical practice and the legal framework for the treatment of type 2 diabetes mellitus patients.
del Pozo-Fernández C; Pardo-Ruiz C; Sánchez-Botella C; Blanes-Castañer V; López-Menchero R; Gisbert-Sellés C; Sánchez-Jodar C; Alvarez-Avellán L
Nefrologia; 2012 May; 32(3):367-73. PubMed ID: 22592422
[TBL] [Abstract][Full Text] [Related]
4. Sulfonylureas.
Kalra S; Gupta Y
J Pak Med Assoc; 2015 Jan; 65(1):101-4. PubMed ID: 25831689
[TBL] [Abstract][Full Text] [Related]
5. Citizen Petition to the US Food and Drug Administration to Change Prescribing Guidelines: The Metformin Experience.
Lipska KJ; Flory JH; Hennessy S; Inzucchi SE
Circulation; 2016 Nov; 134(18):1405-1408. PubMed ID: 27799258
[No Abstract] [Full Text] [Related]
6. [40 years of using sulfonylurea derivatives for treatment of diabetes].
Sieradzki J
Przegl Lek; 1996; 53(9):641-6. PubMed ID: 8992529
[TBL] [Abstract][Full Text] [Related]
7. Effect of CYP2C9 polymorphisms on prescribed dose and time-to-stable dose of sulfonylureas in primary care patients with Type 2 diabetes mellitus.
Swen JJ; Wessels JA; Krabben A; Assendelft WJ; Guchelaar HJ
Pharmacogenomics; 2010 Nov; 11(11):1517-23. PubMed ID: 21121772
[TBL] [Abstract][Full Text] [Related]
8. Sulfonylureas improve insulin binding and insulin action in non-insulin-dependent diabetes mellitus.
Beck-Nielsen H; Hjøllund E; Pedersen O; Richelsen B; Sørensen NS
Diabetes Care; 1984; 7 Suppl 1():100-5. PubMed ID: 6428842
[TBL] [Abstract][Full Text] [Related]
9. [Sulfonylureas].
Sagreira L
Acta Med Port; 1989 Sep; Suppl 1():9S-13S. PubMed ID: 2694782
[TBL] [Abstract][Full Text] [Related]
10. Practical considerations and guidelines for dosing sulfonylureas as monotherapy or combination therapy.
Bell DS
Clin Ther; 2004 Nov; 26(11):1714-27. PubMed ID: 15639686
[TBL] [Abstract][Full Text] [Related]
11. Sulfonylureas: do we need to introspect safety again?
Sehra D; Sehra S; Sehra ST
Expert Opin Drug Saf; 2011 Nov; 10(6):851-61. PubMed ID: 21605015
[TBL] [Abstract][Full Text] [Related]
12. Sulfonylureas and on-clopidogrel platelet reactivity in type 2 diabetes mellitus patients.
Harmsze AM; Van Werkum JW; Moral F; Ten Berg JN; Hackeng CM; Klungel OH; De Boer A; Deneer VH
Platelets; 2011; 22(2):98-102. PubMed ID: 21142408
[TBL] [Abstract][Full Text] [Related]
13. [Mode of action of hypoglycemic sulfanilamides].
Girardin E; Conte Devolx B
Therapie; 1991; 46(4):311-4. PubMed ID: 1948807
[TBL] [Abstract][Full Text] [Related]
14. [Circadian profiles of lactic and pyruvic acid in diabetic patients treated with biguanides and sulfonylureas].
Cheli V; Buzzo P; Melga P; Accoto S; Prando R
Clin Ter; 1986 Aug; 118(4):269-75. PubMed ID: 3757467
[No Abstract] [Full Text] [Related]
15. Sulfonylureas and mortality in diabetic patients after myocardial infarction.
Brady PA; Al-Suwaidi J; Kopecky SL; Terzic A
Circulation; 1998 Feb; 97(7):709-10. PubMed ID: 9495313
[No Abstract] [Full Text] [Related]
16. The views of patients with diabetes about nurse prescribing.
Courtenay M; Stenner K; Carey N
Diabet Med; 2010 Sep; 27(9):1049-54. PubMed ID: 20722679
[TBL] [Abstract][Full Text] [Related]
17. [Combination therapy with sulfonylurea plus insulin in "secondary failure" of type 2 diabetes].
Lotz N
Ther Umsch; 1990 Jan; 47(1):49-54. PubMed ID: 2408182
[TBL] [Abstract][Full Text] [Related]
18. Initiating oral anti diabetic drug: alternatives to metformin.
Kalra S; Gupta Y
J Pak Med Assoc; 2015 Apr; 65(4):440-1. PubMed ID: 25976586
[TBL] [Abstract][Full Text] [Related]
19. Setting the standard.
Rawlings K
Diabetes Forecast; 2013 Feb; 66(2):38-9. PubMed ID: 23405571
[No Abstract] [Full Text] [Related]
20. Oral hypoglycemic agents for treatment of NIDDM.
Skillman TG
Geriatrics; 1984 Sep; 39(9):77-8, 80-3, 87. PubMed ID: 6381231
[No Abstract] [Full Text] [Related]
[Next] [New Search]
